Department of Biomedical Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.
PLoS One. 2024 Jul 29;19(7):e0302636. doi: 10.1371/journal.pone.0302636. eCollection 2024.
Rheumatic heart disease is a global health concern with a persistently high incidence in developing countries, including Africa. It has a significant economic, morbidity, and mortality burden, particularly for children and young adults during their most productive years. However, in the last ten years, the extent of its impact in Africa has remained unclear. Limited studies conducted on the continent have reported diverse prevalence rates of rheumatic heart disease. As a result of these, the study aimed to aggregate and synthesize findings from population-based studies to offer a comprehensive and updated overview of rheumatic heart disease prevalence and pattern at the African level.
The studies were identified through a comprehensive literature search of the electronic databases, including PubMed, Google Scholar, Web searches, and manual searches. The descriptive information for the study is presented in the table, and the quantitative results are presented in forest plots. The Cochrane Q test and I2 test statistic were used to test heterogeneity across studies. The pooled estimate of the prevalence of rheumatic heart disease was computed by a random effects model.
Out of 22 population-based studies analyzed using random-effects, the pooled magnitude of rheumatic heart disease was found to be 18.41/1000 (95% CI: 14.08-22.73/1000). This comprised definite cases of rheumatic heart disease at a prevalence rate of 8.91/1000 (95% CI: 6.50-11.33/1000) and borderline cases at a prevalence rate of 10.69/1000 (95% CI: 7.74-13.65/1000). The combined prevalence of rheumatic heart disease in males was almost equivalent to that in females. Mitral valve regurgitation was the predominant valve affected by rheumatic heart disease, accounting for approximately 73%.
This study analysis found the prevalence of rheumatic heart disease in Africa is high. Because of this, policies and interventions should give attention to prioritize continuous population based active surveillance for early detection of cases to the reduction of rheumatic heart disease sequel, especially in the children and adolescent population.
风湿性心脏病是一个全球性的健康问题,在发展中国家,包括非洲,发病率一直很高。它给经济、发病率和死亡率带来了沉重负担,尤其是在儿童和年轻人最具生产力的年龄段。然而,在过去的十年中,其在非洲的影响程度仍然不清楚。在非洲大陆进行的有限研究报告了风湿性心脏病的流行率各不相同。由于这些原因,该研究旨在汇总和综合基于人群的研究结果,提供非洲层面风湿性心脏病流行率和模式的全面和最新概述。
通过对电子数据库(包括 PubMed、Google Scholar、网络搜索和手动搜索)进行全面文献检索,确定了这些研究。表中呈现了研究的描述性信息,森林图中呈现了定量结果。使用 Cochrane Q 检验和 I2 检验统计量检验研究之间的异质性。采用随机效应模型计算风湿性心脏病的患病率合并估计值。
在使用随机效应分析的 22 项基于人群的研究中,风湿性心脏病的总体患病率为 18.41/1000(95%置信区间:14.08-22.73/1000)。这包括风湿性心脏病的明确病例患病率为 8.91/1000(95%置信区间:6.50-11.33/1000)和边缘病例患病率为 10.69/1000(95%置信区间:7.74-13.65/1000)。风湿性心脏病男性的合并患病率几乎与女性相当。二尖瓣反流是风湿性心脏病的主要受累瓣膜,占比约为 73%。
本研究分析发现,非洲风湿性心脏病的患病率较高。因此,政策和干预措施应重视优先进行基于人群的持续主动监测,以早期发现病例,减少风湿性心脏病的后续影响,特别是在儿童和青少年人群中。